Modis Therapeutics Competitors and Similar CompaniesClear all
Amicus Therapeutics's competitors and similar companies include Bluebird Bio.
 Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | ||
Founding Date | Founding Date 2002 | Founding Date 1992 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations Somerville, US HQ |
Employees | Employees 58415% increase | Employees 32338% decrease |
Valuation ($) | Valuation ($) 3.4 b | Valuation ($) 95.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) $634.2m (FY, 2025) | Revenue (est.) $83.8m (FY, 2024) |
Cost of goods | Cost of goods $72.9m (FY, 2025) | Cost of goods $89.4m (FY, 2024) |
Gross profit | Gross profit $561.3m (FY, 2025) | Gross profit ($5.6m) (FY, 2024) |
Net income | Net income ($27.1m) (FY, 2025) | Net income ($240.7m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 88m | Total funding raised $ 409m |
For sources of this data, please see the company profile
View Company Profiles
Bluebird Bio
HQ
Somerville, US
Employees
323↓ 38% decrease
Bluebird Bio is a developer of gene therapies for severe genetic diseases.
View company